会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 미토콘드리아 기능 조절에 활성을 지닌 트리아졸 유도체
    • 三唑衍生物作为麻醉功能调节剂
    • KR1020130096900A
    • 2013-09-02
    • KR1020120018466
    • 2012-02-23
    • 한국과학기술연구원
    • 민선준조용서배애님이재균이지연정선화박병건
    • C07D403/04C07D249/06A61K31/41A61K31/4025
    • PURPOSE: A triazole derivative is provided to be used as a restorative of mitochondrial dysfunction with effects of treating Alzheimer's diseases, Parkinson's disease, Huntington's disease, ischemic diseases, diabetes, and schizophrenia. CONSTITUTION: A compound is selected among a triazole derivative of chemical formula 1and a pharmaceutically acceptable salt thereof. A pharmaceutical composition for treating Alzheimer's disease, Parkinson's disease, Huntington's disease, ischemic disease, diabetes, and schizophrenia contains the compound as an active ingredient. A method for preparing the triazole compound comprises the step of reacting an azide compound of chemical formula 2 and an ethynyl benzene compound of chemical formula 3 by dipolar cycloaddition.
    • 目的:提供三唑衍生物作为线粒体功能障碍的修复剂,具有治疗阿尔茨海默氏病,帕金森病,亨廷顿病,缺血性疾病,糖尿病和精神分裂症的作用。 构成:化合物选自化学式1的三唑衍生物及其药学上可接受的盐。 用于治疗阿尔茨海默病,帕金森病,亨廷顿病,缺血性疾病,糖尿病和精神分裂症的药物组合物含有该化合物作为活性成分。 制备三唑化合物的方法包括通过偶极环加成使化学式2的叠氮化合物与化学式3的乙炔基苯化合物反应的步骤。
    • 4. 发明公开
    • 신경보호제로서의 유레아 유도체
    • 尿素类似物作为神经保护剂
    • KR1020130115696A
    • 2013-10-22
    • KR1020120038239
    • 2012-04-13
    • 한국과학기술연구원
    • 추현아배애님김지윤박병건이지연노은주박정은라현화
    • C07D211/42C07D241/28A61K31/44A61P25/00
    • PURPOSE: A urea derivative is provided to selectively suppress the action of mPTP in the brain, thereby being used as a neuroprotective agent which improves the action of the mitochondria. CONSTITUTION: A urea derivative is denoted by chemical formula 1. A method for preparing the urea derivative comprises the steps of making a compound of chemical formula 2 react with isocyanate compounds or isothiocyanate compounds. The compound of chemical formula 2 is prepared by making a compound of chemical formula 3 react with benzyl halide compounds. A pharmaceutical composition for suppressing the action of mPTP contains the urea derivative or a pharmaceutically acceptable salt thereof as an active ingredient. A pharmaceutical composition for treating nervous diseases contains the urea derivative or a pharmaceutically acceptable salt thereof as an active ingredient.
    • 目的:提供尿素衍生物以选择性抑制脑中mPTP的作用,从而用作改善线粒体作用的神经保护剂。 构成:以化学式1表示脲衍生物。制备尿素衍生物的方法包括使化学式2的化合物与异氰酸酯化合物或异硫氰酸酯化合物反应的步骤。 通过使化学式3的化合物与苄基卤化合物反应来制备化学式2的化合物。 用于抑制mPTP作用的药物组合物含有尿素衍生物或其药学上可接受的盐作为活性成分。 用于治疗神经疾病的药物组合物含有尿素衍生物或其药学上可接受的盐作为活性成分。